Deciphering the predictors of endometrial nonbenign lesions in asymptomatic postmenopausal women via explainable machine learning
Clinical Snapshot
PICO Framework
| P — Population | 971 asymptomatic postmenopausal women with endometrial thickening |
| I — Intervention | Machine learning-based diagnostic model using 41 clinical characteristics |
| C — Comparator | Nine different machine learning algorithms compared |
| O — Outcomes | Prediction of endometrial nonbenign lesions (sensitivity, specificity, AUC) |
Bottom Line
This study developed a machine learning model to predict endometrial malignancy in asymptomatic postmenopausal women with endometrial thickening, achieving 78% sensitivity and 98% specificity. Key predictors included parity, Doppler flow signals, endometrial thickness, CA-125, and D-dimer. While the high specificity could help avoid unnecessary invasive procedures, several methodological concerns limit confidence in these results. The reference standard for confirming malignancy is not clearly defined, confidence intervals are not provided, and the study lacks sufficient detail for reproducibility. The single-centre Chinese population may limit generalisability to Australian practice. External validation in diverse populations and clearer methodology would strengthen the evidence before clinical implementation. The nomogram approach shows promise but requires further validation.
Key Findings
P Value: Not reported
Effect Size: AUC 0.81 for logistic regression model
Primary Outcome: Prediction of endometrial nonbenign lesions
Nnt Or Sensitivity: Sensitivity 78%, Specificity 98%
Confidence Interval: Not reported
Clinical Application
Requires access to CA-125, D-dimer testing and Doppler ultrasound - readily available in Australian healthcare Could integrate with existing RANZCOG guidelines for postmenopausal bleeding investigation, potentially reducing unnecessary procedures covered by Medicare Asymptomatic postmenopausal women with endometrial thickening detected on imaging
Abstract
OBJECTIVES: Timely identification of endometrial nonbenign lesions led to improved outcomes, but there was a lack of effective predictive models for asymptomatic endometrial thickening. The aim of this study was to develop a strong machine learning (ML) model for assessing the risk of endometrial malignancy in asymptomatic patients after menopause. METHODS: This retrospective study was designed to collect data from 971 postmenopausal asymptomatic women with endometrial thickening. The bootstrap resampling method was used for model training, internal validation, and external validation. With 41 easily accessible characteristics, multifactor regression and least absolute shrinkage and selection operator regression were performed for feature selection. Nine ML algorithms were applied to build a model. To explain the final model and rank feature importance, the SHapley Additive exPlanation (SHAP) method was utilized. Meanwhile, a nomogram was developed to facilitate model interpretation. RESULTS: The comprehensive methodologies identified parity, Doppler flow signals, endometrial thickness, cancer antigen 125, and D-dimer as significant predictors. The logistic regression (LR) model demonstrated superior performance compared with other ML algorithms, achieving an accuracy of 88%, a sensitivity of 78%, a specificity of 98%, and an area under the receiver operating characteristic curve of 0.81. Furthermore, individualized predictions of endometrial malignancy were visualized through a force plot generated by SHAP analysis. A nomogram based on the LR model was subsequently constructed, showing area under the receiver operating characteristic curve values of 0.82, 0.82, and 0.81 for the training, internal validation, and external validation cohorts, respectively. The calibration curve demonstrated excellent consistency. CONCLUSIONS: We developed an LR-based nomogram model and interpreted using the SHAP method, which provided visual insights for detecting endometrial nonbenign lesions in asymptomatic postmenopausal women. This approach would aid clinicians in providing individualized treatment and help avoid unnecessary invasive surgeries.
References
- 1.Yang, L., Xu, C., Su, R., Gao, X., Ye, B., Liu, Y., Wang, J., Chen, Y., Fan, Q., Yuan, J., Lu, X., Yang, D., Li, Y., & Wang, Y. (2026). Deciphering the predictors of endometrial nonbenign lesions in asymptomatic postmenopausal women via explainable machine learning. Menopause, advance online publication. https://doi.org/10.2196/54872
Related Research
Histochemistry and cell biology
Molecular plasticity of LAMA3 across the disease spectrum: pathogenic mechanisms and clinical translation.
29 July 2026
Journal of robotic surgery
Robotic versus laparoscopic and open surgery for endometrial cancer: a systematic review of randomized trials and pooled analysis of conversion rates
21 July 2026
Journal of robotic surgery
Mapping the evolution of deep learning and computer vision in robotic surgery: a bibliometric analysis of surgical video intelligence, instrument perception, and clinical translation.
21 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service